EDGAR Filing Documents for 0001662252-17-000025

Form PRE 14C - Other preliminary information statements:

SEC Accession No. 0001662252-17-000025

Filing Date

2017-02-22

Accepted

2017-02-21 20:37:42

Documents

Period of Report

2017-02-06

Document Format Files

Seq	Description	Document	Type	Size
1	PRE 14C	rchapre14c.htm	PRE 14C	85109
	Complete submission text file	0001662252-17-000025.txt		86180

Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212

Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001

Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: PRE 14C | Act: 34 | File No.: 000-54767 | Film No.: 17626869
SIC: 2834 Pharmaceutical Preparations